Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


25.05.2026

2 Am J Clin Pathol
4 Ann Hematol
1 Biochem Pharmacol
6 Blood
1 Br J Cancer
1 Cancer
1 Eur J Haematol
1 Genes Chromosomes Cancer
3 J Pediatr Hematol Oncol
1 Leuk Lymphoma
2 Leuk Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. SIDDON AJ, Kahlow C, Weinberg OK
    Acute leukemias with expression of CD56.
    Am J Clin Pathol. 2026;165:aqag021.
    PubMed         Abstract available

  2. YAN M, Younes IE, Song J, Zhang L, et al
    Chronic myelomonocytic leukemia without increased classical monocyte subsets exhibits a distinct genetic profile, including frequent CBL mutations.
    Am J Clin Pathol. 2026;165:aqag045.
    PubMed         Abstract available


    Ann Hematol

  3. LINDEMANN A, Gockel G, Garcia-Pardillos G
    Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax - a case series.
    Ann Hematol. 2026;105:292.
    PubMed         Abstract available

  4. BATTEGAY R, Heim D, Dirnhofer S
    Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment.
    Ann Hematol. 2026 May 20. doi: 10.1007/s00277-026-07069.
    PubMed         Abstract available

  5. LI J, Yi S, Nguyen T, Yu W, et al
    Acalabrutinib vs chlorambucil plus rituximab in untreated chronic lymphocytic leukemia: A randomized phase 3 Asian study.
    Ann Hematol. 2026 May 19. doi: 10.1007/s00277-026-07006.
    PubMed         Abstract available

  6. HUANG J, Zheng C, Liu Y, Li C, et al
    Comparative and integrated application of flow cytometry and next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia.
    Ann Hematol. 2026 May 16. doi: 10.1007/s00277-026-07008.
    PubMed         Abstract available


    Biochem Pharmacol

  7. FAN A, Dong M, Fan N, Luo Q, et al
    Exploiting CDA-Mediated metabolism of 5fdC to overcome cytarabine resistance in Malignant myeloid cells leukemia.
    Biochem Pharmacol. 2026;251.
    PubMed         Abstract available


    Blood

  8. SUZUKI A, Shigehiro T, Hirakawa M, Hirano R, et al
    Self-reinforcing IL-1beta signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL.
    Blood. 2026;147:2472-2488.
    PubMed         Abstract available

  9. MONTANARO A, Monica G, Zamponi R, D'Antuono A, et al
    Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.
    Blood. 2026 May 19:blood.2025029901. doi: 10.1182/blood.2025029901.
    PubMed         Abstract available

  10. MUFFLY L, Frey NV, Roloff GW, Park JH, et al
    Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi Study.
    Blood. 2026 May 19:blood.2026033559. doi: 10.1182/blood.2026033559.
    PubMed         Abstract available

  11. VAN GASTEL N
    Old drug, new parasite: targeting leukemia with antifungals.
    Blood. 2026;147:2417-2418.
    PubMed        

  12. DUPLOYEZ N, Joudinaud R, Boudry A, Hunault M, et al
    Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.
    Blood. 2026 May 21:blood.2025032829. doi: 10.1182/blood.2025032829.
    PubMed         Abstract available

  13. GONG X, Liu Y, Fang Q, Gu R, et al
    Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.
    Blood. 2026 May 21:blood.2026033577. doi: 10.1182/blood.2026033577.
    PubMed         Abstract available


    Br J Cancer

  14. CHEN X, Ma X, Yuan L, Wang F, et al
    TCF3::HLF-positive B-ALL: integrated clinical and molecular characterization of 34 cases from a single-center cohort.
    Br J Cancer. 2026;134:1646-1657.
    PubMed         Abstract available


    Cancer

  15. LAI X, Zhu P, Yang L, Liu L, et al
    Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial.
    Cancer. 2026;132:e70467.
    PubMed         Abstract available


    Eur J Haematol

  16. OU W, Yu Y, Zhu X, Jiang J, et al
    Combined Early Steroid Response and MRD Improve Risk Stratification in Pediatric Acute Lymphoblastic Leukemia: The CCCG-ALL-2015 Study.
    Eur J Haematol. 2026 May 18. doi: 10.1111/ejh.70222.
    PubMed         Abstract available


    Genes Chromosomes Cancer

  17. WANG L, Zhong X, Gao F, Wu X, et al
    A Novel MEIS1::NCOA2 Fusion Gene in Acute Myeloid Leukemia.
    Genes Chromosomes Cancer. 2026;65:e70121.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  18. VARKEY A, Hodes A, Camacho-Bydume C, Chen J, et al
    Patchy Multifocal Bone Marrow Disease in a Young Adult Male With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2026 May 20. doi: 10.1097/MPH.0000000000003214.
    PubMed        

  19. ABBAS AA, Taha AM, Alshehri ED
    Communicating Hydrocephalus as a Manifestation of Central Nervous System Relapse of Acute Lymphoblastic Leukemia in a 10-year-old Child.
    J Pediatr Hematol Oncol. 2026 May 20. doi: 10.1097/MPH.0000000000003216.
    PubMed        

  20. BHAYANA S, Sachdev A, Gupta D, Dhamija A, et al
    The Clinico-Therapeutic Challenge of Tuberculosis in Pediatric Acute Leukemia and Stem Cell Transplant Patients: An Experience From a Tertiary Care Center Over 5 Years.
    J Pediatr Hematol Oncol. 2026 May 18. doi: 10.1097/MPH.0000000000003219.
    PubMed         Abstract available


    Leuk Lymphoma

  21. GOSHIMA Y, Saika T, Kado Y, Yamazaki M, et al
    Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan.
    Leuk Lymphoma. 2026 May 22:1-8. doi: 10.1080/10428194.2026.2665793.
    PubMed         Abstract available


    Leuk Res

  22. KIR S, Abdullayeva N, Yilmazer A, Saydam G, et al
    Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.
    Leuk Res. 2026 May 19:108251. doi: 10.1016/j.leukres.2026.108251.
    PubMed         Abstract available

  23. WOUDBERG R, Meiring SM, Sinanovic E
    Economic burden of leukemia diagnosis and treatment in South Africa: A retrospective cost of illness analysis.
    Leuk Res. 2026;166:108252.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum